Naglaa Shoukry, Ph. D., and her team have made a significant breakthrough in their research aiming to limit the progression of liver disease. They have characterized the mechanisms of action of type 3 inflammatory cytokines ...
Oct 27, 2018
0
2
Imperial researchers have found a new cell mechanism that could be used to target tumours in the future.
Jul 31, 2018
0
98
A team of researchers from several institutions in China has found a mechanism that appears to drive the development of a type of liver cancer not caused by alcohol consumption. In their paper published in the journal Science ...
An enzyme that blocks the metabolic processes that contribute to the rapid growth and spread of liver cancer has been discovered, according to a study by researchers at Sanford Burnham Prebys and Weill Cornell Medicine. The ...
Jun 26, 2020
0
94
In a new study of more than 125,000 pregnant women in Sweden, researchers at the Sahlgrenska Academy found that the risk of hepatobiliary cancer and immune-mediated and cardiovascular diseases later in life is higher in women ...
Aug 12, 2015
0
11
While the amazing regenerative power of the liver has been known since ancient times, the cells responsible for maintaining and replenishing the liver have remained a mystery. Now, research from the Children's Medical Center ...
Feb 25, 2021
0
147
A combination of an oral drug, called sorafenib, and a method for injecting microbeads of chemotherapy directly into tumors has been proven safe for liver cancer patients and may improve outcomes for those who have these ...
Sep 30, 2011
0
0
Researchers have identified a potential new drug target in the fight against cancer.
Sep 18, 2019
0
356
Each one of us carries about 38 trillion bacteria around with us in our gut every day—if you wanted to count them all, it would take you more than a million years. How can such a veritable zoo of microbes reside peacefully ...
Feb 13, 2020
0
291
A number of new, highly effective oral treatments for various types of hepatitis C have been approved in the past few years. However, two groups who have not benefitted from the new treatments are patients with hepatitis ...
Apr 30, 2015
0
45
